home All News open_in_new Full Article

Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Study Data at Alzheimer’s Association International Conference

VANCOUVER, British Columbia & DALLAS — Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced it will present new clinical data on ZUNVEYL at the Alzheimer’s Association International Conference (AAIC), taking place July 27–31, 2025, in Toronto, Canada. The Company will […]


today 3 h. ago attach_file Society

attach_file Culture
attach_file Economics
attach_file Politics
attach_file Other
attach_file Culture
attach_file Politics
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Society
attach_file Culture
attach_file Society
attach_file Other
attach_file Other
attach_file Economics
attach_file Sport
attach_file Culture
attach_file Other
attach_file Sport
attach_file Politics


ID: 403616708
Add Watch Country

arrow_drop_down